InspireMD (NYSE:NSPR – Get Free Report) and Orthofix Medical (NASDAQ:OFIX – Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, valuation, earnings, analyst recommendations, risk, institutional ownership and dividends.
Profitability
This table compares InspireMD and Orthofix Medical’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| InspireMD | -320.97% | -55.71% | -46.53% |
| Orthofix Medical | -20.28% | -10.63% | -7.34% |
Earnings and Valuation
This table compares InspireMD and Orthofix Medical’s top-line revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| InspireMD | $6.20 million | 8.55 | -$19.92 million | ($1.08) | -2.09 |
| Orthofix Medical | $746.64 million | 0.68 | -$151.40 million | ($4.14) | -3.30 |
Institutional and Insider Ownership
44.8% of InspireMD shares are owned by institutional investors. Comparatively, 89.8% of Orthofix Medical shares are owned by institutional investors. 21.6% of InspireMD shares are owned by company insiders. Comparatively, 4.7% of Orthofix Medical shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
Volatility & Risk
InspireMD has a beta of 0.83, indicating that its share price is 17% less volatile than the S&P 500. Comparatively, Orthofix Medical has a beta of 1.04, indicating that its share price is 4% more volatile than the S&P 500.
Analyst Ratings
This is a summary of current recommendations and price targets for InspireMD and Orthofix Medical, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| InspireMD | 0 | 0 | 1 | 0 | 3.00 |
| Orthofix Medical | 0 | 3 | 0 | 0 | 2.00 |
InspireMD currently has a consensus target price of $4.85, indicating a potential upside of 114.60%. Orthofix Medical has a consensus target price of $15.50, indicating a potential upside of 13.55%. Given InspireMD’s stronger consensus rating and higher probable upside, research analysts clearly believe InspireMD is more favorable than Orthofix Medical.
Summary
InspireMD beats Orthofix Medical on 8 of the 14 factors compared between the two stocks.
About InspireMD
InspireMD, Inc., a medical device company, focuses on the development and commercialization of MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific. The company offers CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Delivery System, a mesh-covered self-expanding carotid stent; SwitchGuard, a non-invasive transcarotid artery revascularization device; and NGuard EPS for treating acute stroke with tandem lesions. The company sells its products through local distribution partners. InspireMD, Inc. was founded in 2005 and is headquartered in Tel Aviv-Yafo, Israel.
About Orthofix Medical
Orthofix Medical Inc. operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal and orthopedic conditions. This segment also designs, develops, and markets a portfolio of navigation technologies, including tracked surgical tools, intelligent software, and imaging equipment based on machine-vision and optical innovations. The Global Orthopedics segment offers products and solutions that allow physicians to treat various orthopedic conditions related to limb reconstruction and deformity correction unrelated to the spine. This segment designs, develops, and markets external and internal fixation orthopedic products that are coupled with enabling digital technologies to serve the complete patient treatment pathway. It sells its products through distributors and sales representatives to hospitals, healthcare organizations, and healthcare providers. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in 2018. Orthofix Medical Inc. was founded in 1980 and is headquartered in Lewisville, Texas.
Receive News & Ratings for InspireMD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InspireMD and related companies with MarketBeat.com's FREE daily email newsletter.
